Search Results - Lasocki, Arian

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Ischaemic stroke in the setting of glioblastoma: A case series and review of the literature

    Ischaemic stroke in the setting of glioblastoma: A case series and review of the literature by Lasocki, Arian, Gaillard, Frank

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncology

    How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncology by Lasocki, Arian, Hicks, Rodney J.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Multiple myeloma of the spine

    Multiple myeloma of the spine by Lasocki, Arian, Gaillard, Frank, Harrison, Simon J

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Improving the diagnosis of radiation necrosis after stereotactic radiosurgery to intracranial metastases with conventional MRI features: a case series

    Improving the diagnosis of radiation necrosis after stereotactic radiosurgery to intracranial metastases with conventional MRI features: a case series by Lasocki, Arian, Sia, Joseph, Stuckey, Stephen L.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    High-resolution MRI demonstrates that more than 90% of small intracranial melanoma metastases develop in close relationship to the leptomeninges

    High-resolution MRI demonstrates that more than 90% of small intracranial melanoma metastases develop in close relationship to the leptomeninges by Lasocki, Arian, Khoo, Chloe, Lau, Peter K H, Kok, David L, Mcarthur, Grant A

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Bevacizumab as a steroid‐sparing agent during immunotherapy for melanoma brain metastases: A case series

    Bevacizumab as a steroid‐sparing agent during immunotherapy for melanoma brain metastases: A case series by Banks, Patricia D., Lasocki, Arian, Lau, Peter K. H., Sandhu, Shahneen, McArthur, Grant, Shackleton, Mark

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobanking

    Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobanking by Gedye, Craig, Sachchithananthan, Mythily, Leonard, Robyn, Jeffree, Rosalind L, Buckland, Michael E, Ziegler, David S, Graeber, Manuel B, Day, Bryan W, McDonald, Kerrie L, Lasocki, Arian, Nowak, Anna K

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    OR32-06 Opportunistic Assessment of Pituitary Gland with Routine MRI and PET/CT Can Guide in Earlier and Increased Identification of Hypophysitis in Patients Treated with Combination Checkpoint Inhibitors

    OR32-06 Opportunistic Assessment of Pituitary Gland with Routine MRI and PET/CT Can Guide in Earlier and Increased Identification of Hypophysitis in Patients Treated with Combinati... by Galligan, Anna, Iravani, Amir, Lasocki, Arian, Wallace, Roslyn, Weppler, Alison, Au-Yeung, George, Sachithanandan, Nirupa, Chiang, Cherie Ying, Wentworth, John, Colman, Peter Grahame, Kay, Thomas William, Krishnamurthy, Balasubramanian, Sandhu, Shahneen

    Published 2020
    Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    SUN-127 Diagnostic Challenges Associated with the Rising Incidence of Endocrine Toxicity in the Era of Combination Immunotherapy

    SUN-127 Diagnostic Challenges Associated with the Rising Incidence of Endocrine Toxicity in the Era of Combination Immunotherapy by Galligan, Anna, Iravani, Amir, Lasocki, Arian, Wallace, Roslyn, Weppler, Alison, Au-Yeung, George, Sachithanandan, Nirupa, Chiang, Cherie Ying, Wentworth, John, Colman, Peter Grahame, Kay, Thomas William, Krishnamurthy, Balasubramanian, Sandhu, Shahneen

    Published 2020
    Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)

    Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES) by Lau, Peter Kar Han, Feran, Breon, Smith, Lorey, Lasocki, Arian, Molania, Ramyar, Smith, Kortnye, Weppler, Alison, Angel, Christopher, Kee, Damien, Bhave, Prachi, Lee, Belinda, Young, Richard J, Iravani, Amir, Yeang, Hanxian Aw, Vergara, Ismael A, Kok, David, Drummond, Kate, Neeson, Paul Joseph, Sheppard, Karen E, Papenfuss, Tony, Solomon, Benjamin J, Sandhu, Shahneen, McArthur, Grant A

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: